Epigenetic reprogramming of carrier free photodynamic modulator to activate tumor immunotherapy by EZH2 inhibition.

MLA

Zhao, Linping, et al. “Epigenetic Reprogramming of Carrier Free Photodynamic Modulator to Activate Tumor Immunotherapy by EZH2 Inhibition.” Biomaterials, vol. 293, Feb. 2023, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.biomaterials.2022.121952.

APA

Zhao, L., Rao, X., Huang, C., Zheng, R., Kong, R., Chen, Z., Yu, X., Cheng, H., & Li, S. (2023). Epigenetic reprogramming of carrier free photodynamic modulator to activate tumor immunotherapy by EZH2 inhibition. Biomaterials, 293, N.PAG. https://doi.org/10.1016/j.biomaterials.2022.121952

Chicago

Zhao, Linping, Xiaona Rao, Chuyu Huang, Rongrong Zheng, Renjiang Kong, Zuxiao Chen, Xiyong Yu, Hong Cheng, and Shiying Li. 2023. “Epigenetic Reprogramming of Carrier Free Photodynamic Modulator to Activate Tumor Immunotherapy by EZH2 Inhibition.” Biomaterials 293 (February): N.PAG. doi:10.1016/j.biomaterials.2022.121952.